GREZX
Price
$9.58
Change
+$0.01 (+0.10%)
Updated
Dec 3 closing price
Net Assets
311.59M
MGLMX
Price
$16.63
Change
+$0.05 (+0.30%)
Updated
Dec 3 closing price
Net Assets
2.2B
Interact to see
Advertisement

GREZX vs MGLMX

Header iconGREZX vs MGLMX Comparison
Open Charts GREZX vs MGLMXBanner chart's image
GuideStone Funds Global Rl Est Secs I
Price$9.58
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets311.59M
MFS Global Real Estate R4
Price$16.63
Change+$0.05 (+0.30%)
VolumeN/A
Net Assets2.2B
GREZX vs MGLMX Comparison Chart in %
View a ticker or compare two or three
VS
GREZX vs. MGLMX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GREZX is a Buy and MGLMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.2B vs. GREZX (312M). MGLMX pays higher dividends than GREZX: MGLMX (2.48) vs GREZX (2.29). GREZX was incepted earlier than MGLMX: GREZX (19 years) vs MGLMX (11 years). GREZX (1.23) is less costly to investors than MGLMX (0.95). GREZX is a more actively managed with annual turnover of: 153.00 vs. MGLMX (48.00). MGLMX has a lower initial minimum investment than GREZX: MGLMX (0) vs GREZX (1000). GREZX annual gain was more profitable for investors over the last year : 2.59 vs. MGLMX (-3.00). GREZX return over 5 years is better than : 14.14 vs. MGLMX (1.78).
GREZXMGLMXGREZX / MGLMX
Total Expense Ratio1.230.94131%
Annual Report Gross Expense Ratio1.230.95129%
Fund Existence19 years11 years-
Gain YTD8.7273.549246%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets312M2.2B14%
Annual Yield % from dividends2.292.4892%
Returns for 1 year2.59-3.00-86%
Returns for 3 years20.312.99679%
Returns for 5 years14.141.78794%
Returns for 10 years34.8524.74141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc